Plasmodium Falciparum

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Clinical Practices for Treating Severe Malaria Caused by P. Falciparum

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania

The Malaria Heart Disease Study

Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers

Safety and Protective Efficacy of Pb(PfCS@UIS4)

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity

ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum

Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO

PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis